Immun Ageing 21(1):30 Waseem R, Shamsi A, Mohammad T, Hassan MI, Kazim SN, Chaudhary AA, Rudayni HA, Al-Zharani M, Ahmad F, Islam A (2022) FNDC5/irisin: physiology and pathophysiology
Choose Semaglutide If You have established cardiovascular disease (prior heart attack, stroke, stent, peripheral artery disease) You're over 50 with multiple cardiovascular risk factors (hypertension, high LDL, smoking history, family history) You've already lost most of the weight you want to lose and you're switching from short-term weight loss to long-term metabolic protection You want the longest-running real-world safety data on a GLP-1 Choose Tirzepatide If Your primary goal is maximum weight loss in the shortest timeframe You don't have established cardiovascular disease You've plateaued on semaglutide and need stronger appetite suppression You tolerate tirzepatide better (some people get less GI upset on dual agonism) What's Still Available After the FDA Crackdown 503A compounding pharmacies continue to prepare both peptides for documented medical need
The primary function of bolus insulin is to control hyperglycemia following food consumption by storing nutrients
Formulary Updates Insurance formularies change annually
If you are researching retatrutide for weight loss, one of the smartest questions you can ask is not just How much weight can I lose? but What kind of weight am I losing? That distinction matters because the best medical weight loss outcomes are not just about lowering the number on the scale
However, it is commonly prescribed off-label to support weight loss and reduce food cravings when deemed appropriate by a licensed provider
